KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Molina Healthcare (MOH) Share-based Compensation (2016 - 2025)

Historic Share-based Compensation for Molina Healthcare (MOH) over the last 17 years, with Q4 2025 value amounting to $20.0 million.

  • Molina Healthcare's Share-based Compensation rose 1111.11% to $20.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $47.0 million, marking a year-over-year decrease of 5948.28%. This contributed to the annual value of $47.0 million for FY2025, which is 5948.28% down from last year.
  • Latest data reveals that Molina Healthcare reported Share-based Compensation of $20.0 million as of Q4 2025, which was up 1111.11% from -$3.0 million recorded in Q3 2025.
  • Over the past 5 years, Molina Healthcare's Share-based Compensation peaked at $80.0 million during Q3 2022, and registered a low of -$3.0 million during Q3 2025.
  • For the 5-year period, Molina Healthcare's Share-based Compensation averaged around $27.4 million, with its median value being $27.0 million (2023).
  • In the last 5 years, Molina Healthcare's Share-based Compensation skyrocketed by 47142.86% in 2022 and then tumbled by 11000.0% in 2025.
  • Molina Healthcare's Share-based Compensation (Quarter) stood at $23.0 million in 2021, then surged by 247.83% to $80.0 million in 2022, then crashed by 66.25% to $27.0 million in 2023, then crashed by 33.33% to $18.0 million in 2024, then increased by 11.11% to $20.0 million in 2025.
  • Its Share-based Compensation stands at $20.0 million for Q4 2025, versus -$3.0 million for Q3 2025 and $3.0 million for Q2 2025.